Srinika Ranasinghe

Srinika Ranasinghe currently serves as the Associate Director of the Center for Immuno-Oncology at the Dana-Farber Cancer Institute, a role held since February 2018, where responsibilities include collaborating on clinical trials, designing trial protocols, and analyzing biomarker data. Prior experience includes a position as Senior Scientist at the Ragon Institute of MGH, MIT, and Harvard from March 2010 to July 2017, where Srinika established a research strategy demonstrating the existence of CD8+ T cells in virally-infected humans and conducted significant studies on HIV-specific T cell responses. Academic credentials include a Doctor of Philosophy in Immunology and a Bachelor's degree in Biological Sciences, both obtained from the University of Oxford.